Shattuck Labs (STTK) Enterprise Value (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Enterprise Value of -$90.4 million for Q1 2026, down 48.48% year-over-year from -$175.5 million in Q1 2025, and down 15.83% quarter-over-quarter from -$78.1 million in Q4 2025.
Shattuck Labs (STTK) Enterprise Value (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Enterprise Value for 8 consecutive years, with -$90.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 48.48% year-over-year to -$90.4 million; the TTM figure through Mar 2026 stood at -$90.4 million (down 48.48% YoY), while the FY2025 annual figure was -$78.1 million, down 6.96% from the prior year.
- Enterprise Value slipped to -$90.4 million in Q1 2026 per STTK's latest filing, from -$78.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$50.5 million in Q2 2025 and bottomed at -$239.2 million in Q1 2022.
- Historically, Enterprise Value has averaged -$119.6 million across 5 years, with a median of -$105.3 million in 2024.
- Annual changes were most pronounced in 2025 — Enterprise Value surged 52.09% — and 2026, when it tumbled 48.48%.
- Shattuck Labs' Enterprise Value stood at -$161.3 million in 2022, then gained by 19.01% to -$130.6 million in 2023, then surged by 44.12% to -$73.0 million in 2024, then fell by 6.96% to -$78.1 million in 2025, then declined by 15.83% to -$90.4 million in 2026.
- Business Quant data shows STTK's Enterprise Value at -$90.4 million in Q1 2026, -$78.1 million in Q4 2025, and -$86.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | -208.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -208.30 Mn |
| Mar 31, 2026 | -90.42 Mn |
| Dec 31, 2025 | -78.07 Mn |
| Sep 30, 2025 | -86.13 Mn |
| Jun 30, 2025 | -50.47 Mn |
| Mar 31, 2025 | -60.90 Mn |
| Dec 31, 2024 | -72.99 Mn |
| Sep 30, 2024 | -90.06 Mn |
| Jun 30, 2024 | -105.34 Mn |
| Mar 31, 2024 | -114.63 Mn |
| Dec 31, 2023 | -130.63 Mn |
| Sep 30, 2023 | -101.07 Mn |
| Jun 30, 2023 | -117.17 Mn |
| Mar 31, 2023 | -135.50 Mn |
| Dec 31, 2022 | -161.28 Mn |
| Sep 30, 2022 | -185.11 Mn |
| Jun 30, 2022 | -214.24 Mn |
| Mar 31, 2022 | -239.23 Mn |
| Dec 31, 2021 | -268.80 Mn |
| Sep 30, 2021 | -290.22 Mn |